Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Channel Therapeutics Corporation (CHRO) had Return on Equity of 46.89% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.97M |
|
-- |
|
-- |
|
$1.83M |
|
$-1.83M |
|
$-0.13M |
|
$-1.97M |
|
$-1.97M |
|
$-1.97M |
|
$-1.97M |
|
$-1.97M |
|
$-1.97M |
|
$-1.83M |
|
$-1.74M |
|
6.13M |
|
6.13M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$0.91M |
|
-- |
|
-- |
|
$0.91M |
|
$5.11M |
|
-- |
|
-- |
|
$5.11M |
|
$-4.20M |
|
$-4.20M |
|
$-4.20M |
|
6.18M |
|
| Cash Flow Statement Financials | |
$-0.63M |
|
-- |
|
$0.25M |
|
$0.51M |
|
$0.13M |
|
$-0.38M |
|
$0.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.18 |
|
-- |
|
-- |
|
-- |
|
-0.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
46.89% |
46.89% |
|
-215.94% |
|
46.89% |
|
$-0.68 |
|
$-0.10 |
|
$-0.10 |
|